Inclusion Criteria:~* Has a diagnosis of probable Alzheimer's disease based on the National Institute of
Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders
Association (NINCDS-ADRDA) criteria at least 1 year prior to the screening visit.~* Has a score between 12 and
20 inclusive on the MMSE at the screening and baseline visits.~* Has a MRI or CT scan performed within 12
months prior to screening with findings consistent with the diagnosis of dementia due to Alzheimer's disease
without any other clinically significant comorbid pathologies.~* Must be receiving treatment with stable doses
of donepezil HCl and memantine HCl for at least 3 months prior to the screening visit~* Availability of an
eligible and reliable caregiver~* Must be living in the community or an assisted living facility.~* Must be
ambulatory or ambulatory aided (use of cane or walker).~* Is not pregnant or planning to become pregnant during
the study.~* Subject (or subject's legally acceptable representative) and caregiver must sign an Informed
Consent to participate in the study.~
